{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:54:02Z","timestamp":1790906042566,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00265497"],"award-info":[{"award-number":["RS-2023-00265497"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00262087"],"award-info":[{"award-number":["RS-2023-00262087"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013391","name":"Ministry of Education and Human Resources Development","doi-asserted-by":"publisher","award":["NRF-5199990614253"],"award-info":[{"award-number":["NRF-5199990614253"]}],"id":[{"id":"10.13039\/501100013391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-II220621"],"award-info":[{"award-number":["RS-2022-II220621"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59902-z","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:35:13Z","timestamp":1783013713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of cytochrome P450 2C19 genotypes with effectiveness of clopidogrel in ischemic stroke by smoking status"],"prefix":"10.1038","volume":"16","author":[{"given":"Hyungjong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Kwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kwan","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Il","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwook","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung-Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Yul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-762X","authenticated-orcid":false,"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PLATELET Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyuk","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Man","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Koo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Chul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Guk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Yeol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"59902_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa0809171","volume":"360","author":"JL Mega","year":"2009","unstructured":"Mega, J. L. et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360, 354\u2013362 (2009).","journal-title":"N Engl J Med"},{"key":"59902_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMoa0808227","volume":"360","author":"T Simon","year":"2009","unstructured":"Simon, T. et al. Genetic determinants of response to clopidogrel and cardiovascular events. N. Engl. J. Med. 360, 363\u2013375 (2009).","journal-title":"N. Engl. J. Med."},{"key":"59902_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3988\/jcn.2025.0317","volume":"21","author":"H Park","year":"2025","unstructured":"Park, H. et al. Association of clopidogrel genetic polymorphism with efficacy and safety for ischemic stroke or transient ischemic attack: A systematic review and updated meta-analysis. J. Clin. Neurol. 21, 514\u2013526 (2025).","journal-title":"J. Clin. Neurol."},{"key":"59902_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/cpt.2526","volume":"112","author":"CR Lee","year":"2022","unstructured":"Lee, C. R. et al. Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update. Clin. Pharmacol. Ther. 112, 959\u2013967 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"59902_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/heartjnl-2013-304138","volume":"100","author":"ZG Zhao","year":"2014","unstructured":"Zhao, Z. G. et al. The impact of smoking on clinical efficacy and pharmacodynamic effects of clopidogrel: A systematic review and meta-analysis. Heart 100, 192\u2013199 (2014).","journal-title":"Heart"},{"key":"59902_CR6","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","volume":"120","author":"JS Berger","year":"2009","unstructured":"Berger, J. S. et al. Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation 120, 2337\u20132344 (2009).","journal-title":"Circulation"},{"key":"59902_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCULATIONAHA.116.024957","volume":"135","author":"B Ovbiagele","year":"2017","unstructured":"Ovbiagele, B. et al. Effect of clopidogrel by smoking status on secondary stroke prevention. Circulation 135, 315\u2013316 (2017).","journal-title":"Circulation"},{"key":"59902_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2146\/ajhp060414","volume":"64","author":"LA Kroon","year":"2007","unstructured":"Kroon, L. A. Drug interactions with smoking. Am. J. Health Syst. Pharm. 64, 1917\u20131921 (2007).","journal-title":"Am. J. Health Syst. Pharm."},{"key":"59902_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12265-013-9530-8","volume":"7","author":"JR Cho","year":"2014","unstructured":"Cho, J. R. et al. Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery disease. J. Cardiovasc. Transl. Res. 7, 47\u201352 (2014).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"59902_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/ene.13962","volume":"26","author":"T Wang","year":"2019","unstructured":"Wang, T. et al. Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack. Eur. J. Neurol. 26, 1175\u20131182 (2019).","journal-title":"Eur. J. Neurol."},{"key":"59902_CR11","doi-asserted-by":"publisher","first-page":"e250398","DOI":"10.1001\/jamanetworkopen.2025.0398","volume":"8","author":"YH Jung","year":"2025","unstructured":"Jung, Y. H. et al. Cytochrome P450 2C19 Genotypes and Clopidogrel in patients with ischemic Stroke: A nonrandomized clinical Trial. JAMA Netw Open 8, e250398 (2025).","journal-title":"JAMA Netw Open"},{"key":"59902_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2013.03.037","volume":"62","author":"PA Gurbel","year":"2013","unstructured":"Gurbel, P. A. et al. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J. Am. Coll. Cardiol. 62, 505\u2013512 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"59902_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000098059","volume":"57","author":"SW Han","year":"2007","unstructured":"Han, S. W. et al. A new subtype classification of ischemic stroke based on treatment and etiologic mechanism. Eur. Neurol. 57, 96\u2013102 (2007).","journal-title":"Eur. Neurol."},{"key":"59902_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ana.25535","volume":"86","author":"J Xu","year":"2019","unstructured":"Xu, J. et al. Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. Ann. Neurol. 86, 419\u2013426 (2019).","journal-title":"Ann. Neurol."},{"key":"59902_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/STROKEAHA.116.016463","volume":"48","author":"Y Lin","year":"2017","unstructured":"Lin, Y. et al. Impact of glycemic control on efficacy of clopidogrel in transient ischemic attack or minor stroke patients with CYP2C19 genetic variants. Stroke 48, 998\u20131004 (2017).","journal-title":"Stroke"},{"key":"59902_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/23969873221148224","volume":"8","author":"AE Lang","year":"2023","unstructured":"Lang, A. E. et al. Subsequent ischemic stroke and tobacco smoking: A secondary analysis of the POINT trial. Eur. Stroke J. 8, 328\u2013333 (2023).","journal-title":"Eur. Stroke J."},{"key":"59902_CR17","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1161\/STROKEAHA.119.028713","volume":"51","author":"JF Meschia","year":"2020","unstructured":"Meschia, J. F. et al. Efficacy of clopidogrel for prevention of stroke based on CYP2C19 allele status in the POINT trial. Stroke 51, 2058\u20132065 (2020).","journal-title":"Stroke"},{"key":"59902_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jcph.293","volume":"54","author":"RB Horenstein","year":"2014","unstructured":"Horenstein, R. B. et al. Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers. J. Clin. Pharmacol. 54, 865\u2013873 (2014).","journal-title":"J. Clin. Pharmacol."},{"key":"59902_CR19","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2011.1703","volume":"306","author":"JL Mega","year":"2011","unstructured":"Mega, J. L. et al. Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA 306, 2221\u20132228 (2011).","journal-title":"JAMA"},{"key":"59902_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/clpt.2011.132","volume":"90","author":"SA Scott","year":"2011","unstructured":"Scott, S. A. et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin. Pharmacol. Ther. 90, 328\u2013332 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"59902_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jacc.2014.03.051","volume":"64","author":"W Hochholzer","year":"2014","unstructured":"Hochholzer, W. et al. Variability of individual platelet reactivity over time in patients treated with clopidogrel: Insights from the ELEVATE-TIMI 56 trial. J. Am. Coll. Cardiol. 64, 361\u2013368 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"59902_CR22","doi-asserted-by":"publisher","first-page":"e114053","DOI":"10.1371\/journal.pone.0114053","volume":"9","author":"YG Kim","year":"2014","unstructured":"Kim, Y. G. et al. Different influences of hematocrit on the results of two point-of-care platelet function tests, the VerifyNow assay and multiple electrode platelet aggregometry. PLoS ONE 9, e114053 (2014).","journal-title":"PLoS ONE"},{"key":"59902_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/dmd.110.034504","volume":"39","author":"I Washio","year":"2011","unstructured":"Washio, I. et al. Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytes. Drug Metab. Dispos. 39, 1\u20133 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"59902_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clpt.2004.04.003","volume":"76","author":"MS Faber","year":"2004","unstructured":"Faber, M. S. & Fuhr, U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76, 178\u2013184 (2004).","journal-title":"Clin Pharmacol Ther"},{"key":"59902_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5853\/jos.2015.17.2.177","volume":"17","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Smoking is not a good prognostic factor following first-ever acute ischemic stroke. J. Stroke 17, 177\u2013191 (2015).","journal-title":"J. Stroke"},{"key":"59902_CR26","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.3346\/jkms.2024.39.e278","volume":"39","author":"DY Kim","year":"2024","unstructured":"Kim, D. Y. et al. Contemporary statistics of acute ischemic stroke and transient ischemic attack in 2021: Insights from the CRCS-K-NIH registry. J. Korean Med. Sci. 39, e278 (2024).","journal-title":"J. Korean Med. Sci."},{"key":"59902_CR27","doi-asserted-by":"publisher","first-page":"e038031","DOI":"10.1136\/bmjopen-2020-038031","volume":"10","author":"TJ Song","year":"2020","unstructured":"Song, T. J. et al. Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: Protocol for multicentre observational study. BMJ Open 10, e038031 (2020).","journal-title":"BMJ Open"},{"key":"59902_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.7754\/Clin.Lab.2015.141214","volume":"61","author":"HK Kim","year":"2015","unstructured":"Kim, H. K. et al. Comparison of the microarray-based assay, the real-time PCR assay, and the bidirectional sequencing method for CYP2C19 genotyping. Clin. Lab. 61, 1109\u20131112 (2015).","journal-title":"Clin. Lab."},{"key":"59902_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316, 70\u201378 (2016).","journal-title":"JAMA"},{"key":"59902_CR30","doi-asserted-by":"publisher","first-page":"e001652","DOI":"10.1161\/JAHA.114.001652","volume":"4","author":"CW McDonough","year":"2015","unstructured":"McDonough, C. W. et al. CYP2C19 metabolizer status and clopidogrel efficacy in the secondary prevention of small subcortical strokes (SPS3) study. J. Am. Heart Assoc. 4, e001652 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"59902_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston, S. C. et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379, 215\u2013225 (2018).","journal-title":"N Engl J Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59902-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59902-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59902-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:02:36Z","timestamp":1790902956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59902-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59902-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. J. Kim reported receiving grants from Chong Kun Dang Pharmaceutical and Myung In Pharmaceuticals outside the submitted work. No other disclosures were reported.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PLATELET trial received approval from the institutional review board (IRB) of Severance Hospital (approval no. 3\u20132019-0195) and from the IRB of all participating hospitals. Written informed consent was obtained from each participant, or from a legally authorized representative, when necessary, before enrollment. This secondary analysis was reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines to ensure accurate and transparent reporting of observational studies.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30468"}}